The Oncology Institute Statistics
Total Valuation
TOI has a market cap or net worth of $197.49 million. The enterprise value is $260.15 million.
Important Dates
The next estimated earnings date is Tuesday, August 12, 2025, after market close.
| Earnings Date | Aug 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
TOI has 90.18 million shares outstanding. The number of shares has increased by 2.45% in one year.
| Current Share Class | 90.18M |
| Shares Outstanding | 90.18M |
| Shares Change (YoY) | +2.45% |
| Shares Change (QoQ) | +1.91% |
| Owned by Insiders (%) | 12.28% |
| Owned by Institutions (%) | 20.54% |
| Float | 67.66M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.45 |
| Forward PS | n/a |
| PB Ratio | 41.75 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.65 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.79, with a Debt / Equity ratio of 20.20.
| Current Ratio | 1.79 |
| Quick Ratio | 1.50 |
| Debt / Equity | 20.20 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -6.87 |
Financial Efficiency
Return on equity (ROE) is -277.62% and return on invested capital (ROIC) is -24.21%.
| Return on Equity (ROE) | -277.62% |
| Return on Assets (ROA) | -17.66% |
| Return on Invested Capital (ROIC) | -24.21% |
| Return on Capital Employed (ROCE) | -49.83% |
| Revenue Per Employee | $488,669 |
| Profits Per Employee | -$64,010 |
| Employee Count | 825 |
| Asset Turnover | 2.19 |
| Inventory Turnover | 28.82 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +409.30% in the last 52 weeks. The beta is 0.16, so TOI's price volatility has been lower than the market average.
| Beta (5Y) | 0.16 |
| 52-Week Price Change | +409.30% |
| 50-Day Moving Average | 2.71 |
| 200-Day Moving Average | 1.10 |
| Relative Strength Index (RSI) | 38.23 |
| Average Volume (20 Days) | 2,198,613 |
Short Selling Information
The latest short interest is 2.41 million, so 2.67% of the outstanding shares have been sold short.
| Short Interest | 2.41M |
| Short Previous Month | 1.56M |
| Short % of Shares Out | 2.67% |
| Short % of Float | 3.56% |
| Short Ratio (days to cover) | 1.11 |
Income Statement
In the last 12 months, TOI had revenue of $403.15 million and -$52.81 million in losses. Loss per share was -$0.70.
| Revenue | 403.15M |
| Gross Profit | 59.28M |
| Operating Income | -52.06M |
| Pretax Income | -57.85M |
| Net Income | -52.81M |
| EBITDA | -45.48M |
| EBIT | -52.06M |
| Loss Per Share | -$0.70 |
Full Income StatementBalance Sheet
The company has $39.74 million in cash and $102.40 million in debt, giving a net cash position of -$62.66 million or -$0.69 per share.
| Cash & Cash Equivalents | 39.74M |
| Total Debt | 102.40M |
| Net Cash | -62.66M |
| Net Cash Per Share | -$0.69 |
| Equity (Book Value) | 5.07M |
| Book Value Per Share | 0.06 |
| Working Capital | 47.28M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$15.64 million and capital expenditures -$3.51 million, giving a free cash flow of -$19.15 million.
| Operating Cash Flow | -15.64M |
| Capital Expenditures | -3.51M |
| Free Cash Flow | -19.15M |
| FCF Per Share | -$0.21 |
Full Cash Flow StatementMargins
Gross margin is 14.70%, with operating and profit margins of -12.91% and -15.96%.
| Gross Margin | 14.70% |
| Operating Margin | -12.91% |
| Pretax Margin | -15.96% |
| Profit Margin | -15.96% |
| EBITDA Margin | -11.28% |
| EBIT Margin | -12.91% |
| FCF Margin | n/a |
Dividends & Yields
TOI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.45% |
| Shareholder Yield | -2.45% |
| Earnings Yield | -26.74% |
| FCF Yield | -9.70% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TOI has an Altman Z-Score of -0.05 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.05 |
| Piotroski F-Score | 3 |